Need Help? Chat Now With a Live Representative!

Press Release: ARG Names Michael Wisniewski, PhD Vice-President of Statistics and Informatics

Press Release: ARG Names Michael Wisniewski, PhD Vice-President of Statistics and Informatics

Press Release: ARG Names Michael Wisniewski, PhD Vice-President of Statistics and Informatics

March 5, 2019

CHARLOTTESVILLE, Va. and LONDON, March 5, 2019 — Atlantic Research Group (ARG), a global full-service contract research organization (CRO), has announced the hire of Michael Wisniewski, PhD, as Vice-President of Biostatistics and Informatics. The addition significantly strengthens ARG’s leadership and experience in analytics, statistics and programming.

ARG, founded in 2004, is a leader in rare disease, immunology and oncology CRO services. Dr. Wisniewski, with 35 years of experience building and managing teams of biostatisticians and programmers within the research industry>, has previously held positions at GlaxoSmithKline, PPD, Chiltern and Covance.

As a result of the hire, ARG will have an executive in place to help scale its Statistics and Informatics offerings to coincide with the anticipated growth of the organization as a whole.

“Mike's guidance will help ensure our success managing novel and exciting products as we continue to expand globally. We feel fortunate to have him on board,” said Lyle Camblos, ARG’s President and cofounder, adding that Dr. Wisniewski has worked closely with Sponsors and directly with the FDA in order to maximize the success potential of clinical trials.

Dr. Wisniewski chose to join ARG because of its commitment to partnerships with its clients, stating: “We want to deliver strategy and quality in the clinical development process through relationships with the Sponsor. We are building a world-class Biometrics and Data Analytics organization that will leverage statistical knowledge and technology to provide quality expertise and services to our clients.”

ABOUT ARG:

ARG is a rare disease, oncology and immunology-focused contract research organization that provides comprehensive clinical program development services ranging from pre-launch consulting to commercialization. Founded in 2004, ARG has experienced consistent growth across the globe, expanding our reach to include drug and device trial management in diverse and wide-ranging therapeutic areas. ARG has remained true to our original vision: every project is highly significant and visible, delivered through strategic collaboration with partners. ARG successfully operationalizes development projects because we believe everyone deserves to be well.

Please download a PDF of the release here: ARG Names Michael Wisniewski, PhD Vice-President of Statistics and Informatics.

Contact:  Casey LoFrese
ARG Marketing Manager
434-485-5886
[email protected]

ARG and ADMA Biologics Celebrate FDA Approval of Bivigam for Pediatric Population

ARG and ADMA Biologics Celebrate FDA Approval of Bivigam for Pediatric Population

Atlantic Research Group, a pioneer in the immunology space since 2004, proudly announces the FDA approval of Bivigam for pediatric […]

March 18, 2024
ARG Appoints Dr. Victoria Allgood Vice President, Scientific Affairs, Oncology

ARG Appoints Dr. Victoria Allgood Vice President, Scientific Affairs, Oncology

CHARLOTTESVILLE, Va., April 11, 2023 — Victoria Allgood, PhD, has joined Atlantic Research Group (ARG) as Vice President, Scientific Affairs, […]

April 11, 2023
Atlantic Research Group Appoints Jeffrey H. Lawson, MD, PhD Chief Medical Officer

Atlantic Research Group Appoints Jeffrey H. Lawson, MD, PhD Chief Medical Officer

CHARLOTTESVILLE, Va., March 1, 2023 — Jeffrey H. Lawson, MD, PhD has joined Atlantic Research Group (ARG) as Chief Medical […]

March 1, 2023
GO TO TOP